期刊文献+

N-去硫酸肝素对体外培养人胃癌SGC-7901细胞bFGF表达的影响 被引量:1

In vitro effect of N-desulfated heparin on the expression of basic fibroblast growth factor in gastric carcinoma cell line SGC-7901
在线阅读 下载PDF
导出
摘要 目的:探讨N-去硫酸肝素对体外培养人胃癌SGC-7901细胞碱性成纤维细胞生长因子(bFGF)表达的影响.方法:体外培养人胃癌SGC-7901细胞,加入含不同浓度N-去硫酸肝素(0.1、1.0g/L,N-去硫酸肝素组)的RPMI 1640培养液,并设对照(为培养液),每组平行3个样本.培养12、24h,应用双抗体夹心ABC-ELISA法及实时荧光定量PCR法检测胃癌细胞bFGF的表达.结果:与对照组相比,0.1、1.0g/LN-去硫酸肝素组培养12、24h,bFGF的表达下降均有统计学意义(t=7.502,P=0.002;t=55.416,P=0.000;t=52.221,P=0.000;t=48.080,P=0.000);相同时间下各浓度的N-去硫酸肝素组中bFGFmRNA的表达(CT值)较对照组高.N-去硫酸肝素对胃癌细胞bFGF蛋白及mRNA表达的抑制作用具有剂量及时间依赖性.结论:N-去硫酸肝素可以显著抑制体外培养人胃癌细胞bFGF的表达,且具有时间、剂量依赖性. AIM: To investigate the effect of N-desulfated heparin on the expression of basic fibroblast growth factor (bFGF) in human gastric carcinoma SGC-7901 cells in vitro. METHODS: Human gastric carcinoma cell line SGC-7901 was cultured in vitro, and then treated with N-desulfated heparin at different concentrations (0.1, 1.0 g/L). Meanwhile, SGC-7901 cells cultured in single RPMI 1640 medium were used as controls. Each group contained 3 paralleled samples. Enzyme-linked immunosorbent assay (ELISA) and real time polymerase chain reaction (PCR) were used to detect the expression of bFGF in SGC-7901 cells at 12 h and 24 h, respectively. RESULTS: After treatment with 0.1 or 1.0 g/L N-desulfated heparin for 12 or 24 h, bFGF protein expression was decreased significantly (t = 7.502, P = 0.002; t = 55.416, P = 0.000; t = 52.221, P = 0.000; t = 48.080, P = 0.000). The expression of bFGF (CT value) in each N-desulfated heparin group was higher than that in the control group at the same time. The inhibition of N-desulfated heparin on bFGF protein and mRNA expression in SGC-7901 cells was dose- and time-dependent. CONCLUSION: N-desulfated heparin can inhibit the expression of bFGF in gastric cancer cell line SGC-7901 in a dose- and time-dependent manner in vitro.
出处 《世界华人消化杂志》 CAS 北大核心 2008年第17期1920-1925,共6页 World Chinese Journal of Digestology
关键词 N-去硫酸肝素 SGC-7901胃癌细胞 碱性成纤维细胞生长因子 ELISA 实时荧光定量PCR N-desulfated heparin SGC-7901 gastric carcinoma cell Basic fibroblast growth factor ELISA Real time PCR
作者简介 通讯作者:陈金联,200233,上海市第六人民医院消化内科wqq_021002@163.com电话:021-64834597
  • 相关文献

参考文献7

二级参考文献24

  • 1Fang J, Yan L, Shing Y, et al. HIF-1alpha-mediated up-regulation of vascular endothelial growth factor, independent of basic fibroblast growth factor, is important in the switch to the angiogenic phenotype during early tumorigenesis. Cancer Res, 2001, 61:5731-5735.
  • 2Banks RE, Forbes MA, Kinsey SE, et al. Release of the angiogenic cytokine vascular endothelial growth factor (VEGF) from platelets: significance for VEGF measurements and cancer biology. Br J Cancer,1998, 77: 956-964.
  • 3Lin SY, Wang YY, Sheu WH. Preoperative plasma concentrations of vascular endothelial growth factor and matrix metalloproteinase 9 are associated with stage progression in papillary thyroid cancer. Clin Endocrinol (Oxf),2003, 58: 513-518.
  • 4Asahara T, Bauters C, Zheng LP, et al. Synergistic effect of vascular endothelial growth factor and basic fibroblast growth factor on angiogenesis in vivo. Circulation,1995, 92(9 Suppl):365-371.
  • 5Lissoni P, Rovelli F, Malugani F, et al. Changes in circulating VEGF levels in relation to clinical response during chemotherapy for metastatic cancer. Int J Biol Markers, 2003,18:152-155.
  • 6Ueno K, Inoue Y, Kawaguchi T, et al. Increased serum levels of basic fibroblast growth factor in lung cancer patients: relevance to response of therapy and prognosis. Lung Cancer,2001, 31: 213-219.
  • 7Song S, Wientjes MG, Gan Y, et al. Fibroblast growth factors: an epigenetic mechanism of broad spectrum resistance to anticancer drugs. Proc Natl Acad Sci USA, 2000, 97: 8658-8663.
  • 8Folkman J, Shing Y. Angiogenesis. J Biol Chem, 1992, 267: 10931-10934.
  • 9Lutsenko SV, Kiselev SM, Severin SE. Molecular mechanisms of tumor angiogenesis. Biochemistry (Mosc), 2003, 68: 286-300.
  • 10Tamura M, Ohta Y, Kajita T, et al. Plasma VEGF concentration can predict the tumor angiogenic capacity in non-small cell lung cancer. Oncol Rep, 2001,8:1097-1102.

共引文献61

同被引文献2

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部